Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
January 24, 2026Clinical Journal of the American Society of Nephrology

A New Hope for Treating Podocytopathies — Emerging Role of Anti-Nephrin Antibody

View Full Paper
Ask AI
Bookmark
Share

Authors

NLNastassia LiaukouskayaFHFelicitas E. HengelAMAnne K. Mühlig

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Liaukouskaya et al. (2026) studied this question.

synapsesocial.com/papers/6975659fd5e0d64addde79c5https://doi.org/10.2215/cjn.0000001008
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Anti-nephrin, anti-podocin and anti-Kirrel1 antibodies: Biological challenges and clinical implications.2025
  2. 2Serum Factors in Primary Podocytopathies2025
  3. 3Autoantibodies targeting CRB2 and Nephrin correlate with extrafollicular B cells in idiopathic podocytopathies2025
  4. 4How to Cure Autoimmune Glomerulonephritis and Podocytopathies2025
  5. 5Anti-CD20 therapies and anti-nephrin autoantibodies in IgA nephropathy with minimal change disease2026